Stockreport

Starlight Therapeutics Announces Inaugural Members of Scientific Advisory Board

Lantern Pharma Inc.  (LTRN) 
PDF DALLAS--(BUSINESS WIRE)--Starlight Therapeutics, a wholly-owned subsidiary of Lantern Pharmaceuticals (NASDAQ: LTRN), formed to develop transformative CNS cancer tre [Read more]